Alert Data News | Business | Companies | UK | Pharmaceuticals

Alliance Boots Holdings Limited

Mon, 21 May 2012 10:32:13 +0100

Revenue up 18% to 23bn - international expansion strategy
Alliance Boots recorded an 18% increase in revenue to 23bn in the year to March 2012. Trading profit increased 12.4% to 1.2bn. The strong performance was achieved through organic growth and acquisitions. The group expects profitable growth and international expansion to continue despite the difficult economic environment.

GlaxoSmithKline PLC

Thu, 17 May 2012 11:00:02 +0100

Cellzone fully acquired - Company growth -
GlaxoSmithKline have entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million

Renovo Group PLC

Mon, 14 May 2012 08:08:08 +0100

£30m acquisition fund - withdraws from drug development
Biotechnology company Renovo is investing £30m in mergers and acquisitions after ceasing its drug development activities. Renovo made all its 100 employees redundant in 2011 following unsuccessful trials of its Juvista product. It has also ceased development of Adaprev and Prevascar and is focusing on mergers and acquisitions and a share buy-back programme.

GlaxoSmithKline PLC

Mon, 14 May 2012 02:50:03 +0100

Bid for Human Genome Sciences increased - US expansion
Pharmaceutical company GlaxoSmithKline (GSK) has strengthened its £1.6bn takeover bid for US biotech firm Human Genome Sciences (HSG). GSK is launching a tender offer of 13 dollars per share in cash. HSG rejected an earlier bid from GSK because it believed it undervalued the company. 2011 turnover £27.38bn, 97,401 employees.

Pfizer Group Limited

Wed, 09 May 2012 08:04:04 +0100

Lipitor sales fall 42% - decline in revenues and profits - baby food business disposal
Pharmaceutical company Pfizer recorded a 19% fall in 2012 first-quarter profits to £1.1bn after sales of its Lipitor cholesterol treatment fell 42% due to competition from cheaper generic alternatives. Revenues fell 7% to 15.4bn dollars. Pfizer is selling its baby food business to Nestle for £7.4 billion.

Vectura Group Plc

Tue, 08 May 2012 08:00:08 +0100

Board Appointment - Turnover 42.9m - 260 Employees
Vectura Group plc, which specialises in developing therapies, principally for the treatment of respiratory diseases, have appointed Dr Trevor Phillips, Chief Operations Officer to the board. Jack Cashman is Chairman.

Lofthouse Of Fleetwood Limited

Wed, 02 May 2012 08:35:05 +0100

Sales up £2.6m - Profit rises - £5m investment in facilities
Sales at Lancashire based Fishermans Friend producer Lofthouse of Fleetwood have risen by £2.6m. Overall profit was £4.22m, up from £4.03m. Pre-tax profit fell from £5.61m to £5.38m. The company has also invested £5m on its 'Pharma Suite' project which involved the purchase and installation of new packaging equipment which started operation in 2012. Doreen, James A and Duncan Lofthouse are Directors of the company.

AstraZeneca UK Ltd

Wed, 02 May 2012 08:28:46 +0100

Profits fall 19 per cent - Chief Executive resigns - New Chairman appointed
London based multinational pharmaceutical and biologics company, AstraZeneca, has recorded a 19 per cent fall in profits for the first quarter to March 2012. Chief Executive David Brennan is to step down from his position in June 2012. Mr Brennan will be replaced on an interim basis by Chief Financial Officer Simon Lowth while a permanent successor is found. In addition, Leif Johansson will succeed Louis Schweitzer as Non-Executive Chairman.

Alliance Boots Holdings Limited

Wed, 02 May 2012 08:12:17 +0100

160 Photo Lab Closures - 200 Possible Job Losses - 53800 Employees
Boots are to close 160 in-store photo labs putting up to 200 jobs at risk. Alternative roles will be sought for staff affected.